Feverfew has been used for
thousands of years to treat several common conditions and ailments.
Historically, feverfew was used as a fewer reducer, pain reliever, and
treatment for female reproductive problems. In modern naturopathy, feverfew is
a popular and effective treatment for migraine headaches.
Although
safe when used as directed, feverfew can cause serious problems in a few
individuals. Some people should not take feverfew. If you call into any of
these categories, use feverfew supplements only under the close supervision of
a qualified practitioner.
Pregnant Women
Pregnant
women should not use feverfew, because it has been used historically to induce
labor and promote menstruation. If you use feverfew during pregnancy, you may
experience a miscarriage or preterm labor. Compounds in feverfew may also harm
the development of the baby's brain.
Breastfeeding Mothers
Nursing
moms should not take feverfew supplements except under the guidance of a health
care provider. A few small-scale studies have indicated that it is safe, but
more trials are needed to prove these results. Feverfew may be safer than
narcotics such as morphine for treating migraine in nursing moms, but check
with your child's pediatrician before taking any supplement.
People with Ragweed Allergies
Feverfew
may cause allergic reactions in some individuals. As a member of the ragweed
family, which also includes daisies, chamomile and echinacea, feverfew can be
considered highly allergenic. Use caution when taking feverfew if you have a
ragweed allergy. Read here for more information about the use of
medicinal herbs for people with ragweed allergies.
People who will Need Surgery
Feverfew
may hinder blood clotting, possibly leading to excessive blood loss during
surgery. If you are going to have surgery within the next two weeks, including
a minor procedure such as dental extraction, do not use feverfew. If you have
used feverfew and need emergency surgery, tell your doctor so that she can take
additional precauations to prevent excessive bleeding.
No comments:
Post a Comment